Kaneda Y - Search Results

1

Tumor necrosis factor-a antisense transfer remarkably improves hepatic graft viability.

Yoshizumi T, Yonemitsu Y, Ikeda Y, Kaneda Y, Yanaga K, Sugimachi K, Sueishi K. Yoshizumi T, et al. Among authors: kaneda y. Liver Int. 2006 May;26(4):451-6. doi: 10.1111/j.1478-3231.2006.01252.x. Liver Int. 2006. PMID: 16629649

2

Transluminal gene transfer into brain capillary endothelial cells in vivo with HVJ-liposomes.

Jiang C, Matsuo H, Koyabu N, Ohtani H, Fujimoto H, Yonemitsu Y, Kaneda Y, Narro M, Tsuruo T, Sawada Y. Jiang C, et al. Among authors: kaneda y. J Drug Target. 2002 Jun;10(4):345-52. doi: 10.1080/10611860290031822. J Drug Target. 2002. PMID: 12164383

3

Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes.

Tomita N, Morishita R, Yamamoto K, Higaki J, Dzau VJ, Ogihara T, Kaneda Y. Tomita N, et al. Among authors: kaneda y. J Gene Med. 2002 Sep-Oct;4(5):527-35. doi: 10.1002/jgm.300. J Gene Med. 2002. PMID: 12221646

4

Antisense in vivo knockdown of synaptotagmin I and synapsin I by HVJ-liposome mediated gene transfer modulates ischemic injury of hippocampus in opposing ways.

Iwakuma M, Anzai T, Kobayashi S, Ogata M, Kaneda Y, Ohno K, Saji M. Iwakuma M, et al. Among authors: kaneda y. Neurosci Res. 2003 Mar;45(3):285-96. doi: 10.1016/s0168-0102(02)00233-x. Neurosci Res. 2003. PMID: 12631464

5

Suppression of oxidative stress-induced hepatocyte injury by calpain antisense.

Taniguchi K, Umeshita K, Sakon M, Miyoshi H, Tokunaga M, Ariyoshi H, Yamano T, Kaneda Y, Monden M. Taniguchi K, et al. Among authors: kaneda y. J Surg Res. 2003 May 1;111(1):23-7. doi: 10.1016/s0022-4804(03)00047-7. J Surg Res. 2003. PMID: 12842444

6

Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.

Ogushi I, Iimuro Y, Seki E, Son G, Hirano T, Hada T, Tsutsui H, Nakanishi K, Morishita R, Kaneda Y, Fujimoto J. Ogushi I, et al. Among authors: kaneda y. Hepatology. 2003 Aug;38(2):335-44. doi: 10.1053/jhep.2003.50298. Hepatology. 2003. PMID: 12883477

7

Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats.

Kato N, Nemoto K, Nakanishi K, Morishita R, Kaneda Y, Uenoyama M, Ikeda T, Fujikawa K. Kato N, et al. Among authors: kaneda y. Diabetes. 2005 Mar;54(3):846-54. doi: 10.2337/diabetes.54.3.846. Diabetes. 2005. PMID: 15734864

8

The effect of gene transfer with hepatocyte growth factor for pulmonary vascular hypoplasia in neonatal porcine model.

Ono M, Sawa Y, Miyamoto Y, Fukushima N, Ichikawa H, Ishizaka T, Kaneda Y, Matsuda H. Ono M, et al. Among authors: kaneda y. J Thorac Cardiovasc Surg. 2005 Apr;129(4):740-5. doi: 10.1016/j.jtcvs.2004.06.040. J Thorac Cardiovasc Surg. 2005. PMID: 15821638 Free article.

9

HVJ-based non-viral gene transfer method: successful gene therapy using HGF and VEGF genes in experimental ischemia.

Shimamura M, Sato N, Yoshimura S, Kaneda Y, Morishita R. Shimamura M, et al. Among authors: kaneda y. Front Biosci. 2006 Jan 1;11:753-9. doi: 10.2741/1833. Front Biosci. 2006. PMID: 16146767 Review.

10

Total vascular exclusion safely facilitates liver specific gene transfer by the HVJ (sendai virus)-liposome method in rats.

Kawashita Y, Fujioka H, Ohtsuru A, Kuroda H, Eguchi S, Kaneda Y, Yamashita S, Kanematsu T. Kawashita Y, et al. Among authors: kaneda y. J Surg Res. 2006 May;132(1):136-41. doi: 10.1016/j.jss.2005.09.027. Epub 2005 Dec 9. J Surg Res. 2006. PMID: 16337969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,114 results

Search Page

Filters